Home ›› 22 Dec 2021 ›› Corporate
JMI Group will investment around Tk 52 million for increasing production capacity of syringes for all diseases including covid-19 vaccination.
Mohammad Tareq Hossain Khan, Company Secretary of JMI Syringes and Medical Devices Limited revealed the information at the 226th board meeting of the company through virtual platform on Monday.
The company had approved an investment of $ 6,14,984 (Tk 52 million) for the purchase of equipment and other accessories required to increase the production capacity of syringes, said a media statement on Tuesday.
Amount of the new investment will come from the regular income of the company, added the company
secretary.
JMI Group Chairman Md Jabed Iqbal Padan, Managing Director Md Abdur Razzak, nominated directors of Japan's Nipro Corporation at JMI Syringes and Medical Devices Ltd Katsuhiko Fujii and Hisao Nakamori, among others, were present in the meeting.
